Long‐Term Effects of Direct‐Acting Antivirals on Hepatitis C: Trends in Liver Disease–Related Hospitalisations in Italy
This study aimed to evaluate the effectiveness of direct-acting antivirals (DAAs) on hepatitis C virus (HCV) hospitalisation trends in Italy, the country with not only the highest burden of HCV-related disease but also the highest number of patients treated for chronic HCV infection in Europe. Incident hospital discharge records in Italy from 2012 to 2019 that included a liver cirrhosis diagnosis without mention of alcohol, hepatocellular carcinoma (HCC), HCV and liver cirrhosis without mention of alcohol and/or HCC, cirrhosis with mention of alcohol, as defined by the International Classification of Diseases (ICD-9-CM) were reviewed. An interrupted time series analysis compared the incidence of cirrhosis and HCC before and after the introduction of DAAs (Year 2015). Overall, non-alcoholic cirrhosis significantly decreased after the introduction of DAAs (β<sub>3</sub> = 0.03) and for those 40-59 years of age (β<sub>3</sub> = 0.025). HCV with cirrhosis and/or HCC significantly reduced overall for those aged 40-59 and older than 60 ( <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics> <mml:mrow><mml:msub><mml:mi>β</mml:mi> <mml:mn>3</mml:mn></mml:msub> <mml:mo>=</mml:mo> <mml:mn>0.002</mml:mn></mml:mrow> <mml:annotation>$$ {\beta}_3=0.002 $$</mml:annotation></mml:semantics> </mml:math> ). HCC-related hospitalisation rates significantly decreased in patients younger than 60 ( <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics> <mml:mrow><mml:msub><mml:mi>β</mml:mi> <mml:mn>3</mml:mn></mml:msub> <mml:mo>=</mml:mo> <mml:mn>0.03</mml:mn></mml:mrow> <mml:annotation>$$ {\beta}_3=0.03 $$</mml:annotation></mml:semantics> </mml:math> ). Cirrhosis-related hospitalisations with mention of alcohol did not differ during the study period before and after the year 2015 ( <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics> <mml:mrow><mml:msub><mml:mi>β</mml:mi> <mml:mn>3</mml:mn></mml:msub> <mml:mo>=</mml:mo> <mml:mn>0.4</mml:mn></mml:mrow> <mml:annotation>$$ {\beta}_3=0.4 $$</mml:annotation></mml:semantics> </mml:math> ). There was a significant reduction in HCV-related hospitalisations throughout Italy after introducing DAAs.
Authors
- Andrea Marcellusi (ORCID: https://orcid.org/0000-0002-3974-3798)
- Claudia Simonelli
- Paolo Sciattella (ORCID: https://orcid.org/0000-0002-8364-1895)
- Stefano Rosato (ORCID: https://orcid.org/0000-0002-6690-5537)
- Loreta A. Kondili
- Francesco Saverio Mennini
Institutions
- University of Rome Tor Vergata (IT)
- Istituto Superiore di Sanità (IT)
- Ministero della Salute (IT)
- Saint Camillus International University of Health and Medical Sciences (IT)
- Albanian University (AL)
Publication Details
- Journal
- Journal of Viral Hepatitis
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1111/jvh.14061
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00